| 000 | 01652 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514165543.0 | ||
| 264 | 0 | _c20040206 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a1537-6591 | ||
| 024 | 7 |
_a10.1086/380791 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGallego, Lucía | |
| 245 | 0 | 0 |
_aAnalyzing sleep abnormalities in HIV-infected patients treated with Efavirenz. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cFeb 2004 |
||
| 300 |
_a430-2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlkynes |
| 650 | 0 | 4 | _aBenzoxazines |
| 650 | 0 | 4 | _aCyclopropanes |
| 650 | 0 | 4 | _aElectroencephalography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOxazines _xadverse effects |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aSleep Initiation and Maintenance Disorders _xchemically induced |
| 650 | 0 | 4 |
_aSleep Stages _xdrug effects |
| 650 | 0 | 4 |
_aSleep Wake Disorders _xchemically induced |
| 700 | 1 | _aBarreiro, Pablo | |
| 700 | 1 | _adel Río, Rafael | |
| 700 | 1 | _aGonzález de Requena, Daniel | |
| 700 | 1 | _aRodríguez-Albariño, Apolinar | |
| 700 | 1 | _aGonzález-Lahoz, Juan | |
| 700 | 1 | _aSoriano, Vincent | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 38 _gno. 3 _gp. 430-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/380791 _zAvailable from publisher's website |
| 999 |
_c14453712 _d14453712 |
||